<DOC>
	<DOCNO>NCT01387672</DOCNO>
	<brief_summary>Purpose : NABT : To compare five widely available nitrate formulation : ( 1 ) 15 nitroglycerin ( NTG ) ointment , ( 2 ) 0.3 mg ( 3 ) 0.6 mg sublingual NTG , ( 4 ) 20 mg isosorbide mononitrate ( oral tablet ) , ( 5 ) 160 mg glycerol trinitrate ( patch ) , efficacy marker bone formation resorption incidence severity headache cause . Hypothesis : There one ideal nitrate preparation balance clinical efficacy bone remodel common side effect headache . NABT-B : To determine nitrate affect marker bone formation ( serum BALP P1NP ) resorption ( serum CTX urine NTX ) woman recently discontinue treatment alendronate , risedronate zoledronate .</brief_summary>
	<brief_title>Nitrates Bone Turnover ; Nitrates Bone Turnover Bisphosphonate Sub-Study</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>NABT : Women age 50 year old whose last menstrual period occur least 3 year ago Women without uterus eligible age 55 NABTB : Women age 50 year old whose last menstrual period occur least 3 year ago Women without uterus eligible age 55 Previously treat alendronate stop within 2 year study commencement ; previously treat risedronate stop within 1 year study commencement ; previously treat zoledronate . NABT : A previous fracture hip , wrist , spine ankle within last 3 month ; diagnosis osteoporosis ; A history bone disorder hyperparathyroidism Paget 's disease ; Treatment within 12 month study entry agent may influence bone metabolism include hormone , antiestrogen raloxifene prednisone ( equivalent 5 mg/d 12 month great ) ; Treatment antiresorptive agent , include alendronate , risedronate , etidronate denosumab use least four week within last three year ; Previous treatment intravenous zoledronate parathyroid hormone ; Current treatment nitrate ; A history migraine headache ; A history angina cardiovascular disease ; Inability give informed consent ; Hypersensitivity nitroglycerin . NABTB : A previous fracture hip , wrist , spine ankle ; selfreported diagnosis osteoporosis ; A history bone disorder hyperparathyroidism Paget 's disease ; Treatment within 12 month study entry agent may influence bone metabolism include hormone , antiestrogen raloxifene prednisone ( equivalent 5 mg/d 12 month great ) ; Treatment etidronate denosumab use least four week within last three year previous treatment parathyroid hormone ; Current treatment nitrate ; A history migraine headache ; A history angina cardiovascular disease ; Inability give informed consent ; Hypersensitivity nitroglycerin .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>postmenopausal</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>bone turnover</keyword>
	<keyword>nitrate</keyword>
	<keyword>headache</keyword>
</DOC>